AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ETAMSYLATE
26 registrations across 8 African markets— 23 active
Markets with ETAMSYLATE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| DICYNONE Solution for Injection | 🇷🇼Rwanda | DELPHARM | active | Aug 2029 |
| Sylate 500 tablets Tablet Uncoated | 🇿🇲Zambia | Emcure Pharmaceuticals Limited | active | Jun 2029 |
| DICYNONE 250MG/2ML SOLUTION INJECTABLE BOITE DE 4 | 🇨🇮Côte d'Ivoire | OM PHARMA SA | active | Aug 2026 |
| DICYNONE 500MG GELULE BOITE DE 20 | 🇨🇮Côte d'Ivoire | OM PHARMA SA | active | Aug 2026 |
| DICYNONE Solution injectable / 250 MG | 🇹🇳Tunisia | VIFOR FRANCE | expired | Aug 2019 |
| DICYNONE Comprimé / 500 MG | 🇹🇳Tunisia | VIFOR FRANCE | expired | Dec 2018 |
| DICYNONE Comprimé / 250 MG | 🇹🇳Tunisia | VIFOR FRANCE | expired | Dec 2018 |
| PHARMASYLATE solution injectable / 250 mg / 2 ml | 🇸🇳Senegal | PHARMACO | active | — |
| PHARMASYLATE comprimé / 500 mg | 🇸🇳Senegal | PHARMACO | active | — |
| DICYNONE gélule / 500 mg | 🇸🇳Senegal | OM PHARMA | active | — |
| DICYNONE solution injectable / 250 mg / 2 ml | 🇸🇳Senegal | OM PHARMA | active | — |
| DICYNONE 250MG/2ML SOL INJ IM/IV BT(4) AMP(2ML) OM solution injectable IM/IV boite | 🇲🇬Madagascar | OM PHARMA | active | — |
| DICYNONE gélule / 500 mg | 🇸🇳Senegal | OM PHARMA | active | — |
| DICYNONE solution injectable / 250 mg / 2 ml | 🇸🇳Senegal | OM PHARMA | active | — |
| SAVICYLATE 250MG/2ML SOL INJ BT(1x6) AMP(2ML) SAVVY CARE & solution injectable, boite de 1 | 🇲🇬Madagascar | SAVVY CARE & COSMETICS Pvt | active | — |
| Sylate 500 tablets Tablets | 🇹🇿Tanzania | Emcure Pharmaceuticals Ltd | active | — |
| SYLATE comprimé / 250 mg | 🇸🇳Senegal | EMCURE PHARMACEUTICALS LTD | active | — |
| DICYNONE COMPRIME | 🇲🇦Morocco | — | active | — |
| DICYNONE SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| SAVICYLATE 250MG/2ML SOL INJ BT(1x6) AMP(2ML) SAVVY CARE & solution injectable, boite de 1 | 🇲🇬Madagascar | SAVVY CARE & COSMETICS Pvt | active | — |
| DICYNONE® 500MG GELU BTE (2X10) OM PHARMA SA gélule, boite de 20 | 🇲🇬Madagascar | OM PHARMA | active | — |
| DICYNONE 250MG/2ML SOL INJ IM/IV BT(4) AMP(2ML) OM solution injectable IM/IV boite | 🇲🇬Madagascar | OM PHARMA | active | — |
| DICYNONE® 500MG GELU BTE (2X10) OM PHARMA SA gélule, boite de 20 | 🇲🇬Madagascar | OM PHARMA | active | — |
| PHARMASYLATE solution injectable / 250 mg / 2 ml | 🇸🇳Senegal | PHARMACO | active | — |
| DICYNONE COMPRIME | 🇲🇦Morocco | — | active | — |
| PHARMASYLATE comprimé / 500 mg | 🇸🇳Senegal | PHARMACO | active | — |
ETAMSYLATE in Africa — Regulatory Overview
ETAMSYLATE is registered across 8 African markets with 26 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Senegal, Madagascar, Morocco, Tunisia and 4 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 26 registrations, 23 (88%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.